Cigna director defers pay into phantom stock units

Kurian George reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Kurian George reported acquisition or exercise transactions in this Form 4 filing.

The Cigna Group director George Kurian received 108.1471 Phantom Stock Units on May 29, 2026 as a grant under the company’s director deferred compensation plan. These units reflect a voluntary deferral of his cash retainer at $277.40 per unit and are economically equivalent to common shares but will be settled in cash. Following this award and related dividend reinvestments, he holds a total of 1,922.4494 phantom stock units linked to Cigna common stock.

Insider Trade Summary

Grant/Award: 108.1471 shares

Grant/Award 1 txn

Insider Kurian George

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock Units	108.1471	$277.40	$30K

Holdings After Transaction: Phantom Stock Units — 1,922.4494 contracts (Direct)

Footnotes (2)

1. F1. Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash.
2. F2. Includes 10.6351 phantom stock units acquired pursuant to a dividend reinvestment feature of the Deferral Plan.

Key Figures

Phantom units granted: 108.1471 units Implied grant price: $277.40 per unit Total phantom units held: 1,922.4494 units +1 more

4 metrics

Phantom units granted 108.1471 units Phantom Stock Units granted on May 29, 2026

Implied grant price $277.40 per unit Value per Phantom Stock Unit at grant

Total phantom units held 1,922.4494 units Phantom Stock Units held after the transaction

Dividend reinvestment units 10.6351 units Phantom units from dividend reinvestment feature

Key Terms

Phantom Stock Units, Deferred Compensation Plan of 2005 for Directors, hypothetical stock fund, dividend reinvestment feature

4 terms

Phantom Stock Units financial

"The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer"

Phantom stock units are company promises that pay a cash or stock-equivalent award tied to the firm’s share price or value growth, but they do not issue actual shares. Think of them as a bonus check that moves with the stock like a mirror rather than handing over an ownership slice. Investors care because these awards can affect a company’s future cash obligations, executive incentives and reported expenses without causing share dilution.

Deferred Compensation Plan of 2005 for Directors financial

"Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment"

hypothetical stock fund financial

"into the hypothetical stock fund under the Deferral Plan"

dividend reinvestment feature financial

"Includes 10.6351 phantom stock units acquired pursuant to a dividend reinvestment feature of the Deferral Plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Cigna Group (CI) report for George Kurian?

Cigna Group reported that director George Kurian received 108.1471 Phantom Stock Units on May 29, 2026. The award comes from voluntarily deferring part of his director cash retainer into the company’s deferred compensation plan tied to Cigna’s common stock performance.

What are Phantom Stock Units in the Cigna Group (CI) Form 4 filing?

The Phantom Stock Units are bookkeeping entries under Cigna’s director Deferral Plan, each economically equivalent to one Cigna common share. They track share value but are settled in cash rather than stock when paid, reflecting deferred compensation rather than an open-market share purchase.

How many Cigna Group (CI) phantom units does George Kurian hold after this transaction?

After this grant, George Kurian holds 1,922.4494 Phantom Stock Units linked to Cigna common stock. This total includes the 108.1471 units awarded from his deferred cash retainer and additional units accumulated through the plan’s dividend reinvestment feature over time.

Did George Kurian buy or sell Cigna Group (CI) common stock in this Form 4?

The filing shows no open-market buying or selling of Cigna common stock by George Kurian. Instead, he acquired 108.1471 Phantom Stock Units as deferred compensation, which are cash-settled rights tied to the stock’s value rather than actual share purchases or sales.

What role does dividend reinvestment play in Cigna Group (CI) phantom units?

The Deferral Plan includes a dividend reinvestment feature that credits additional Phantom Stock Units when dividends are paid. The filing notes that Kurian’s holdings include 10.6351 phantom units acquired through this reinvestment, incrementally increasing his deferred, cash-settled exposure to Cigna’s stock performance.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/02/2026 - 05:13 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kurian George

(Last) (First) (Middle)

900 COTTAGE GROVE ROAD

(Street)

BLOOMFIELD CONNECTICUT 06002

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cigna Group [ CI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock Units(1)	(1)	05/29/2026		A		108.1471		(1)	(1)	Common Stock, $.01 Par Value	108.1471	$277.4	1,922.4494	D(2)

Explanation of Responses:

1. Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash.

2. Includes 10.6351 phantom stock units acquired pursuant to a dividend reinvestment feature of the Deferral Plan.

Remarks:

	Tyler Gratton, attorney-in-fact	06/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)